Eternity in Medical Information -- Medisurf
Search | Web Directory, News, Variable useful Information, PubMed In Medine, All
Category Select :
Items 381 ~ 400 of 26060, Page 20 of 1303
381. Statement from FDA Commissioner Scott Gottlieb, M.D., on signing of the Agriculture Improvement Act and the agency’s regulation of products containing cannabis and cannabis-derived compounds
12/20/2018 U.S. FOOD & DRUG ADMINISTRATION
382. New Study Finds Higher than Expected Number of Suicide Deaths among U.S. Veterinarians
Female veterinarians at particularly high suicide risk
12/20/2018 Centers for Disease Control and Prevention
383. LYNPARZA® (olaparib) Approved by FDA for First-Line Maintenance Therapy in BRCA-Mutated Advanced Ovarian Cancer
AstraZeneca and Merck’s LYNPARZA Reduced the Risk of Disease Progression or Death by 70 Percent Compared to Placebo Following Response to Platinum-Based Chemotherapy / First PARP Inhibitor Approved in First-Line Maintenance for BRCAm Advanced Ovarian Cancer
12/19/2018 MERCK
384. Almost 4% of Cancers Worldwide Due to Excess Body Weight
Excess body weight is responsible for an estimated 544,300 cancers, which is about 3.9% of all cancers in the world, according to research by the American Cancer Society, Imperial College London, and the Harvard T.H. Chan School of Public Health.
12/19/2018 American Cancer Society
385. Medtronic Completes Acquisition of Mazor Robotics
Company Integrates Robotics and Aims to Make Spine Surgery More Predictable and Transform Outcomes for Hospitals, Surgeons, and Patients
12/19/2018 Medtronic
386. FDA Approves Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Adult and Pediatric Patients with Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma, a Rare Form of Skin Cancer
Accelerated Approval Based on Results of CITN-09/KEYNOTE-017, Where KEYTRUDA Monotherapy Demonstrated an Objective Response Rate of 56 percent
12/19/2018 MERCK
387. Get Bubbly this New Year with Abbott''s New Pedialyte® Sparkling Rush™ Powder Packs
Pedialyte Sparkling Rush is advanced rehydration with a fizz, with an optimal balance of electrolytes and carbohydrate to prevent mild to moderate dehydration
12/19/2018 Abbott
388. Statement from FDA Commissioner Scott Gottlieb, M.D. on the FDA’s 2017 report on declining sales/distribution of antimicrobial drugs for food animals, a reflection of improved antimicrobial stewardship
12/18/2018 U.S. FOOD & DRUG ADMINISTRATION
389. Statement from FDA Commissioner Scott Gottlieb, M.D., and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on new steps to promote innovations in medical devices that help advance patient safety
12/18/2018 U.S. FOOD & DRUG ADMINISTRATION
390. MRI Effective for Monitoring Liver Fat in Obese Patients
Liver fat in 50 patients was assessed before and after bariatric surgery using chemical shift-encoded MRI (CSE-MRI), a safe and noninvasive technique.
12/18/2018 Radiological Society of North America
391. FDA Approves Smart Programmer for the InterStim System
Intuitive and Discreet Device Provides Sacral Neuromodulation Therapy for Overactive Bladder and Bowel Incontinence
12/17/2018 Medtronic
392. European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy for Adults with Resected Stage III Melanoma
European Approval Based on Significant Recurrence-Free Survival Benefit Demonstrated with KEYTRUDA in the Pivotal Phase 3 EORTC1325/KEYNOTE-054 Trial / First Approval for KEYTRUDA in an Adjuvant Setting in the European Union
12/17/2018 MERCK
393. Michigan-based food manufacturer agrees to stop operations after repeated food safety violations
12/17/2018 U.S. FOOD & DRUG ADMINISTRATION
394. 1 in 4 Nonsmoking Americans is Still Exposed to Secondhand Smoke
After 2 ½ decades of progress, efforts to reduce exposure to secondhand smoke among non-smokers have stalled in the US, according to new data from the Centers for Disease Control and Prevention (CDC).
12/17/2018 American Cancer Society
395. Abbott Hosts Conference Call for Fourth-Quarter Earnings
ABBOTT PARK, Ill., Dec. 17, 2018 /PRNewswire/ --?Abbott (NYSE: ABT)?will announce its fourth-quarter 2018 financial results on Wednesday, Jan. 23, 2019, before the market opens.
12/17/2018 Abbott
396. Merck to Acquire Privately Held Antelliq Group
Establishes Merck Animal Health as a Leader in Emerging Digital Tracking, Traceability and Monitoring Technology / Complements Merck Animal Health Portfolio of Vaccines and Pharmaceuticals
12/14/2018 MERCK
397. Abbott Raises Quarterly Dividend 14%, Increasing Payouts for 47 Straight Years
The board of directors of Abbott (NYSE: ABT) today increased the company''''s quarterly common dividend to 32 cents per share, marking a 14 percent increase.
12/14/2018 Abbott
398. 3-Time Cancer Survivor Finds Comfort at Hope Lodge
Cervical and breast cancer survivor Christine E. Sprecher needed treatment for a long-term side effect but had no place to stay until she found the American Cancer Society Hope Lodge program.
12/14/2018 American Cancer Society
399. Statement from FDA Commissioner Scott Gottlieb, M.D. and Director of FDA’s Center for Drug Evaluation and Research Janet Woodcock, M.D., on efforts to modernize generic drug labels while maintaining the efficiency of generic development
12/13/2018 U.S. FOOD & DRUG ADMINISTRATION
400. Nearly 30 million sick and premature newborns in dire need of treatment every year
Global coalition calls for better care and stronger legislation to save babies on the brink of death
12/13/2018 WHO
   
11 12 13 14 15 16 17 18 19 20
 
경기도 성남시 분당구 구미동 25-1 엘레강스 프라자 ㈜ 메디서프 | Tel : 031-896-0930 | 사업자 등록번호 : 212-81-47247
통신판매신호번호 : 경기 성남 2007-712 | 대표이사 한상욱